| scholarly article | Q13442814 |
| P819 | ADS bibcode | 2013PLoSO...871071Z |
| P356 | DOI | 10.1371/JOURNAL.PONE.0071071 |
| P932 | PMC publication ID | 3744527 |
| P698 | PubMed publication ID | 23967153 |
| P5875 | ResearchGate publication ID | 256073072 |
| P2093 | author name string | Lian Duan | |
| Fei Ren | |||
| Guo-feng Li | |||
| Sheng-qi Wang | |||
| Ya-bin Sun | |||
| Bo-xin Zhao | |||
| Qi-lu Huo | |||
| P2860 | cites work | Regulatory role of human AP-endonuclease (APE1/Ref-1) in YB-1-mediated activation of the multidrug resistance gene MDR1. | Q24315064 |
| Multidrug resistance in cancer: role of ATP-dependent transporters | Q28208049 | ||
| Death receptors: signaling and modulation | Q28280897 | ||
| Reversal of multidrug resitance by natural substances from plants | Q28288384 | ||
| Procyanidin B3 prevents articular cartilage degeneration and heterotopic cartilage formation in a mouse surgical osteoarthritis model | Q28729755 | ||
| Biochemistry of multidrug resistance mediated by the multidrug transporter | Q29616476 | ||
| 2-acetylaminofluorene up-regulates rat mdr1b expression through generating reactive oxygen species that activate NF-kappa B pathway | Q31446898 | ||
| Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human breast carcinoma. | Q53942408 | ||
| Nuclear expression of YB-1 protein correlates with P-glycoprotein expression in human osteosarcoma. | Q54124131 | ||
| MDR1 genotype is associated with hepatic cytochrome P450 3A4 basal and induction phenotype. | Q54610889 | ||
| NF-κB-mediated Induction ofmdr1bExpression by Insulin in Rat Hepatoma Cells | Q56029439 | ||
| Grape seed procyanidin b2 inhibits human aortic smooth muscle cell proliferation and migration induced by advanced glycation end products | Q84901798 | ||
| Microplate screening of the differential effects of test agents on Hoechst 33342, rhodamine 123, and rhodamine 6G accumulation in breast cancer cells that overexpress P-glycoprotein | Q33183490 | ||
| Phosphorylation of cold shock domain/Y-box proteins by ERK2 and GSK3beta and repression of the human VEGF promoter | Q33292543 | ||
| Flavonoid dimers as bivalent modulators for p-glycoprotein-based multidrug resistance: structure-activity relationships | Q33418462 | ||
| Multiple physiological functions for multidrug transporter P-glycoprotein? | Q33818793 | ||
| Inhibition of P-glycoprotein function by procyanidine on blood-brain barrier | Q34015834 | ||
| Multidrug resistance (MDR) in cancer. Mechanisms, reversal using modulators of MDR and the role of MDR modulators in influencing the pharmacokinetics of anticancer drugs | Q34060806 | ||
| Induction of human MDR1 gene expression by 2-acetylaminofluorene is mediated by effectors of the phosphoinositide 3-kinase pathway that activate NF-kappaB signaling | Q34124356 | ||
| A surface glycoprotein modulating drug permeability in Chinese hamster ovary cell mutants | Q34488592 | ||
| A pharmacodynamic study of docetaxel in combination with the P-glycoprotein antagonist tariquidar (XR9576) in patients with lung, ovarian, and cervical cancer. | Q34768677 | ||
| Forced expression of heat shock protein 27 (Hsp27) reverses P-glycoprotein (ABCB1)-mediated drug efflux and MDR1 gene expression in Adriamycin-resistant human breast cancer cells | Q35312427 | ||
| Characterisation and manipulation of docetaxel resistant prostate cancer cell lines | Q35462077 | ||
| Apoptosis defects and chemotherapy resistance: molecular interaction maps and networks | Q35743146 | ||
| Nuclear receptors in the multidrug resistance through the regulation of drug-metabolizing enzymes and drug transporters. | Q35919726 | ||
| Multidrug resistance: retrospect and prospects in anti-cancer drug treatment. | Q36536479 | ||
| Pycnogenol: a blend of procyanidins with multifaceted therapeutic applications? | Q37769664 | ||
| A review on biological, nutraceutical and clinical aspects of French maritime pine bark extract | Q37806396 | ||
| YB-1 is upregulated during prostate cancer tumor progression and increases P-glycoprotein activity | Q38343224 | ||
| Downregulation of gene MDR1 by shRNA to reverse multidrug-resistance of ovarian cancer A2780 cells | Q39306820 | ||
| Dietary flavanols exert different effects on antioxidant defenses and apoptosis/proliferation in Caco-2 and SW480 colon cancer cells. | Q39468414 | ||
| Oroxylin A reverses multi-drug resistance of human hepatoma BEL7402/5-FU cells via downregulation of P-glycoprotein expression by inhibiting NF-κB signaling pathway. | Q39545301 | ||
| Upregulation of mdr1 gene is related to activation of the MAPK/ERK signal transduction pathway and YB-1 nuclear translocation in B-cell lymphoma | Q39596590 | ||
| Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer | Q39616068 | ||
| MiR-27a modulates MDR1/P-glycoprotein expression by targeting HIPK2 in human ovarian cancer cells | Q39681268 | ||
| Reversal of MDR1/P-glycoprotein-mediated multidrug resistance by vector-based RNA interference in vitro and in vivo | Q40345597 | ||
| Proanthocyanidins from grape seeds inhibit expression of matrix metalloproteinases in human prostate carcinoma cells, which is associated with the inhibition of activation of MAPK and NF kappa B. | Q40595966 | ||
| Overexpression of extracellular matrix metalloproteinase inducer in multidrug resistant cancer cells | Q40655908 | ||
| The MDR phenotype is associated with the expression of COX-2 and iNOS in a human hepatocellular carcinoma cell line | Q40742257 | ||
| Structure-activity relationship of verapamil analogs and reversal of multidrug resistance. | Q41283411 | ||
| Modification of cytotoxic drug resistance by non-immuno-suppressive cyclosporins | Q41812714 | ||
| Activation of phospholipase C induces the expression of the multidrug resistance (MDR1) gene through the Raf-MAPK pathway. | Q42825460 | ||
| Regulation of MDR1 expression and drug resistance by a positive feedback loop involving hyaluronan, phosphoinositide 3-kinase, and ErbB2. | Q46398274 | ||
| Co-expression of Y box-binding protein-1 and P-glycoprotein as a prognostic marker for survival in epithelial ovarian cancer | Q47727696 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 8 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | multiple drug resistance | Q643839 |
| NF-κB | Q411114 | ||
| P304 | page(s) | e71071 | |
| P577 | publication date | 2013-01-01 | |
| P1433 | published in | PLOS One | Q564954 |
| P1476 | title | Grape seed procyanidin reversal of p-glycoprotein associated multi-drug resistance via down-regulation of NF-κB and MAPK/ERK mediated YB-1 activity in A2780/T cells | |
| P478 | volume | 8 |
| Q48604832 | A miR-20a/MAPK1/c-Myc regulatory feedback loop regulates breast carcinogenesis and chemoresistance |
| Q26799171 | A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition |
| Q28389419 | Adaptive cellular stress pathways as therapeutic targets of dietary phytochemicals: focus on the nervous system |
| Q36413392 | Afatinib reverses multidrug resistance in ovarian cancer via dually inhibiting ATP binding cassette subfamily B member 1. |
| Q92633975 | Alleviation of Multidrug Resistance by Flavonoid and Non-Flavonoid Compounds in Breast, Lung, Colorectal and Prostate Cancer |
| Q37707536 | Antimicrobial peptide LL-37 promotes YB-1 expression, and the viability, migration and invasion of malignant melanoma cells |
| Q42642866 | Cancer Chemopreventive Potential of Procyanidin |
| Q45641138 | Comparative Aspects of Molecular Mechanisms of Drug Resistance through ABC Transporters and Other Related Molecules in Canine Lymphoma |
| Q35485774 | Effect of shikonin on multidrug resistance in HepG2: The role of SIRT1. |
| Q89896532 | Effects of Inhibin A on Apoptosis and Proliferation of Bovine Granulosa Cells |
| Q60955679 | Enhancement of Berberine Hypoglycemic Activity by Oligomeric Proanthocyanidins |
| Q60951976 | Grape Seed Proanthocyanidin Extract Inhibits Human Esophageal Squamous Cancerous Cell Line ECA109 via the NF-B Signaling Pathway |
| Q26995750 | Induction of cellular and molecular immunomodulatory pathways by vitamin A and flavonoids |
| Q38697712 | Inhibition of paclitaxel resistance and apoptosis induction by cucurbitacin B in ovarian carcinoma cells |
| Q37663392 | Inhibition of the multidrug resistance P-glycoprotein: time for a change of strategy? |
| Q38372575 | Molecular mechanisms of drug resistance and its reversal in cancer |
| Q48054785 | Naringin and Sertraline Ameliorate Doxorubicin-Induced Behavioral Deficits Through Modulation of Serotonin Level and Mitochondrial Complexes Protection Pathway in Rat Hippocampus |
| Q39354491 | Natural Products as Alternative Choices for P-Glycoprotein (P-gp) Inhibition. |
| Q92709473 | Proanthocyanidins of Natural Origin: Molecular Mechanisms and Implications for Lipid Disorder and Aging-Associated Diseases |
| Q59072649 | Regulations of P-Glycoprotein/ABCB1/MDR1 in Human Cancer Cells |
| Q41229885 | Remodeling the blood-brain barrier microenvironment by natural products for brain tumor therapy |
| Q88961883 | Research Progress on Reversing Multidrug Resistance in Tumors by Using Chinese Medicine |
| Q47110599 | Role of P-glycoprotein on CD69+CD4+ cells in the pathogenesis of proliferative lupus nephritis and non-responsiveness to immunosuppressive therapy |
| Q31153145 | Serum inhibin A and inhibin B levels in epithelial ovarian cancer patients |
| Q38919533 | Silencing NOB1 enhances doxorubicin antitumor activity of the papillary thyroid carcinoma in vitro and in vivo |
| Q51069587 | Silencing of Y-box binding protein-1 by RNA interference inhibits proliferation, invasion, and metastasis, and enhances sensitivity to cisplatin through NF-κB signaling pathway in human neuroblastoma SH-SY5Y cells. |
| Q42144400 | Tuberostemonine reverses multidrug resistance in chronic myelogenous leukemia cells K562/ADR |
Search more.